Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization.
about
Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivoTowards programming immune tolerance through geometric manipulation of phosphatidylserine.Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery.Harnessing nanoparticles for immune modulationNanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells.Tolerogenic Nanoparticles to Treat Islet Autoimmunity.Enhancing vaccine effectiveness with delivery technology.Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?Intranasal delivery of nanoparticle-based vaccines.Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease.Advanced manufacturing of microdisk vaccines for uniform control of material properties and immune cell function.Neutrophil-Particle Interactions in Blood Circulation Drive Particle Clearance and Alter Neutrophil Responses in Acute Inflammation.Modulating the immune system through nanotechnology.Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery.Switching the Immunogenicity of Peptide Assemblies Using Surface Properties.Engineering nanoparticles to overcome barriers to immunotherapy.Flexible Macromolecule versus Rigid Particle Retention in the Injected Skin and Accumulation in Draining Lymph Nodes Are Differentially Influenced by Hydrodynamic Size.
P2860
Q28388765-0AB8F17E-A19F-4D34-B1E2-D8B73950218BQ30751004-31C7633A-9413-411C-9E5D-388F4BCF8926Q36087004-EF2296CC-D3FB-4E62-A77E-7089B346F955Q36154772-048C3672-D233-4C8C-B65F-12E198EB7C1EQ36821628-B8CCD8E9-2217-42B4-95D2-B497B4B67E34Q38645059-F20212FF-A748-4589-98B9-4E2FA71A475CQ38765636-29C35386-E961-43B0-A34B-4C8D345B852EQ38886698-8FC24CDA-12E1-4E09-8C7A-57F8EEFA8EFDQ39113247-87A0FB4B-CB53-490D-B721-56BEE93C34F4Q45817911-FCBB4A12-CB03-4B62-A4CD-694791A987CBQ47312662-D238EE68-CF60-4972-AB08-1418D929B2FCQ47447868-7E5A1B9B-A43C-4934-933D-53D0326F5E1CQ48630939-F5E62D93-3356-4A82-BA75-1C508FF8497BQ48938733-C66A849D-3252-4CF9-8D08-A2F595F8654DQ49023254-4AB02EF2-21A5-4D17-B58A-F4C817D0854EQ54991276-F2DEA738-7A49-4D11-A5B1-37DC08F72458Q55162750-E93EF3D5-2D58-4F8A-A92E-F50D6F327810
P2860
Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Controlled analysis of nanopar ...... lowing pulmonary immunization.
@ast
Controlled analysis of nanopar ...... lowing pulmonary immunization.
@en
Controlled analysis of nanopar ...... lowing pulmonary immunization.
@nl
type
label
Controlled analysis of nanopar ...... lowing pulmonary immunization.
@ast
Controlled analysis of nanopar ...... lowing pulmonary immunization.
@en
Controlled analysis of nanopar ...... lowing pulmonary immunization.
@nl
prefLabel
Controlled analysis of nanopar ...... lowing pulmonary immunization.
@ast
Controlled analysis of nanopar ...... lowing pulmonary immunization.
@en
Controlled analysis of nanopar ...... lowing pulmonary immunization.
@nl
P2093
P2860
P921
P356
P1476
Controlled analysis of nanopar ...... lowing pulmonary immunization.
@en
P2093
Gregory R Robbins
Jenny P Y Ting
Joseph M DeSimone
Marc P Kai
Tammy W Shen
P2860
P304
P356
10.1073/PNAS.1422923112
P407
P577
2014-12-29T00:00:00Z